Cargando…
Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications
As the field of translational ‘omics has progressed, refined classifiers at both genomic and proteomic levels have emerged to decipher the heterogeneity of breast cancer in a clinically-applicable way. The integration of ‘omics knowledge at the DNA, RNA and protein levels is further expanding biolog...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434975/ https://www.ncbi.nlm.nih.gov/pubmed/36050786 http://dx.doi.org/10.1186/s13046-022-02476-1 |